Positive inotropic and negative lusitropic effects of endotlielin receptor agonism in vivo

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 289, Issue 4 58-4, 2005, Pages

  Konrad, D ^a,c   Oldner, A ^a   Wanecek, M ^a   Rudehill, A ^a   Weitzberg, E ^a   Biber, B ^b   Johansson, G ^b   Haggmark S ^b   Haney, M ^b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UMEÅ UNIVERSITY   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cardiac; Diastolic; End systolic elastance; Inotropy; Porcine; Sarafotoxin

Indexed keywords

ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; ENDOTHELIN B RECEPTOR; ENDOTHELIN B RECEPTOR AGONIST; SARAFOTOXIN S6C;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CORONARY ARTERY CONSTRICTION; FEMALE; HEART FUNCTION; HEART INFARCTION; HEART LEFT VENTRICLE PRESSURE; HEART LEFT VENTRICLE RELAXATION; HEART PRELOAD; INOTROPISM; NONHUMAN; PRIORITY JOURNAL; SWINE;

ANESTHESIA; ANIMALS; CARDIOTONIC AGENTS; CORONARY CIRCULATION; DIASTOLE; ENDOTHELIN-1; FEMALE; HEART; INJECTIONS, INTRAVENOUS; MYOCARDIAL CONTRACTION; OXYGEN; RECEPTOR, ENDOTHELIN B; RECEPTORS, ENDOTHELIN; SUS SCROFA; VASOCONSTRICTOR AGENTS; VENTRICULAR PRESSURE; VIPER VENOMS;

EID: 25444452359     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00892.2004     Document Type: Article

References (49)

1. Arai H, Hori S, Aramori I, Ohkubo H, and Nakanishi S. Cloning and expression of a cDNA encoding an endothelin receptor. Nature 348: 730-732, 1990.
2. Asano K, Bohlmeyer TJ, Westcott JY, Zisman L, Kinugawa K, Good M, Minobe WA, Roden R, Wolfel EE, Lindenfeld J, David Port J, Perryman MB, Clevel J, Lowes BD, and Bristow MR. Altered expression of endothelin receptors in failing human left ventricles. J Mol Cell Cardiol 34: 833-846, 2002.
3. B receptor antagonists. Br J Pharmacol 120: 516-522, 1997.
4. Balfors E, Haggmark S, Ariola S Jr, Biber B, Ponten J, and Reiz S. In vitro analysis of thermal transport in coronary sinus thermodilution catheters. Clin Physiol 3: 469-476, 1983.
5. -ε and blunted positive inotropic response to endothelin-1. Cardiovasc Res 50: 486-494, 2001.
6. Beyer ME, Slesak G, Nerz S, Kazmaier S, and Hoffmeister HM. Effects of endothelin-1 and IRL 1620 on myocardial contractility and myocardial energy metabolism. J Cardiovasc Pharmacol 26, Suppl 3: S150-S152, 1995.
7. Broome M, Haney M, Osterlund B, Haggmark S, Johansson G, and Biber B. The cardiac effects of intracoronary angiotensin II infusion. Anesth Analg 94: 787-793, 2002.
8. Brutsaert DL and Sys SU. Relaxation and diastole of the heart. Physiol Rev 69: 1228-1315, 1989.
9. Cirino M, Martin E, Yano M, and Rodger IW. Cardiovascular and renal actions of the endothelin(B) receptor in pigs. J Cardiovasc Pharmacol 29: 704-712, 1997.
10. de Nucci G, Thomas R, D'Orleans-Juste P, Antunes E, Walder C, Warner TD, and Vane JR. Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor. Proc Natl Acad Sci USA 85: 9797-9800, 1988.
11. Ergul A, Walker CA, Goldberg A, Baicu SC, Hendrick JW, King MK, and Spinale FG. ET-1 in the myocardial interstitium: relation to myocyte ECE activity and expression. Am J Physiol Heart Circ Physiol 278: H2050-H2056, 2000.
12. Glower DD, Spratt JA, Snow ND, Kabas JS, Davis JW, Olsen CO, Tyson GS, Sabiston DC Jr, and Rankin JS. Linearity of the Frank-Starling relationship in the intact heart: the concept of preload recruitable stroke work. Circulation 71: 994-1009, 1985.
13. Goldberg AT, Bond BR, Mukherjee R, New RB, Zellner JL, Crawford FA Jr, and Spinale FG. Endothelin receptor pathway in human left ventricular myocytes: relation to contractility. Ann Thorac Surg 69: 711-716, 2000.
14. Haney MF, Johansson G, Haggmark S, and Biber B. Method of preload reduction during LVPVR analysis of systolic function: airway pressure elevation and vena cava occlusion. Anesthesiology 97: 436-446, 2002.
15. Hemsén A. Biochemical and functional characterization of endothelin peptides with special reference to vascular effects. Acta Physiol Scand Suppl 602: 1-61, 1991.
16. Ishikawa T, Li LM, Shinmi O, Kimura S, Yanagisawa M, Goto K, and Masaki T. Characteristics of binding of endothelin-1 and endothelin-3 to rat hearts. Developmental changes in mechanical responses and receptor subtypes. Circ Res 69: 918-926, 1991.
17. Kass DA and Maughan WL. From "Emax" to pressure-volume relations: a broader view. Circulation 77: 1203-1212, 1988.
18. Kass DA, Maughan WL, Guo ZM, Kono A, Sunagawa K, and Sagawa K. Comparative influence of load versus, inotropic states on indexes of ventricular contractility: experimental and theoretical analysis based on pressure-volume relationships. Circulation 76: 1422-1436, 1987.
19. Kiely DG, Cargill RI, Struthers AD, and Lipworth BJ. Cardiopulmonary effects of endothelin-1 in man. Cardiovasc Res 33: 378-386, 1997.
20. Konrad D, Oldner A, Rossi P, Wanecek M, Rudehill A, and Weitzberg E. Differentiated and dose-related cardiovascular effects of a dual endothelin receptor antagonist in endotoxin shock. Crit Care Med 32: 1192-1199, 2004.
21. + exchanger. Circ Res 68: 269-279, 1991.
22. Lerman A, Kubo SH, Tschumperlin LK, and Burnett JC Jr. Plasma endothelin concentrations in humans with end-stage heart failure and after heart transplantation. J Am Coll Cardiol 20: 849-853, 1992.
23. A receptor antagonist. Circulation 101: 142-147, 2000.
24. Mirsky I. Assessment of diastolic function: suggested methods and future considerations. Circulation 69: 836-841, 1984.
25. Modesti PA, Vanni S, Paniccia R, Perna A, Maccherini M, Lisi G, Sani G, and Neri Serneri G. Endothelin receptors in adult human and swine isolated ventricular cardiomyocytes. Biochem Pharmacol 58: 369-374, 1999.
26. Molenaar P, O'Reilly G, Sharkey A, Kuc RE, Harding DP, Plumpton C, Gresham GA, and Davenport AP. Characterization and localization of endothelin receptor subtypes in the human atrioventricular conducting system and myocardium. Circ Res 72: 526-538, 1993.
27. Nakayama M, Chen CH, Nevo E, Fetics B, Wong E, and Kass DA. Optimal preload adjustment of maximal ventricular power index varies with cardiac chamber size. Am Heart J 136: 281-288, 1998.
28. Oldner A, Wanecek M, Weitzberg E, Sundin P, Sollevi A, Rubio C, Hellstrom PM, Alving K, and Rudehill A. Differentiated effects on splanchnic homeostasis by selective and non-selective endothelin receptor antagonism in porcine endotoxaemia. Br J Pharmacol 127: 1793-1804, 1999.
29. Pearl JM, Nelson DP, Wagner CJ, Lombardi JP, and Duffy JY. Endothelin receptor blockade reduces ventricular dysfunction and injury after reoxygenation. Ann Thorac Surg 72: 565-570, 2001.
30. Plumpton C, Ferro CJ, Haynes WG, Webb BJ, and Davenport AP. The increase in human plasma immunoreactive endothelin but not big endothelin-1 or its C-terminal fragment induced by systemic administration of the endothelin antagonist TAK-044. Br J Pharmacol 119: 311-314, 1996.
31. Pollock DM and Opgenorth TJ. Evidence for endothelin-induced renal vasoconstriction independent of ETA receptor activation. Am J Physiol Regul Integr Comp Physiol 264: R222-R226, 1993.
32. Qi XL, Sia YT, Stewart DJ, Wei G, Nguyen QT, Cernacek P, Picard P, Sirois M, and Rouleau JL. Myocardial contractile responsiveness to endothelin-1 in the postinfarction rat model of heart failure: effects of chronic quinapril. J Mol Cell Cardiol 33: 2023-2035, 2001.
33. Ry SD, Andreassi MG, Clerico A, Biagini A, and Giannessi D. Endothelin-1, endothelin-1 receptors and cardiac natriuretic peptides in failing human heart. Life Sci 68: 2715-2730, 2001.
34. Sakurai K, Norota I, Tanaka H, Kubota I, Tomoike H, and Endo M. Negative inotropic effects of angiotensin II, endothelin-1 and phenylephrine in indo-1 loaded adult mouse ventricular myocytes. Life Sci 70: 1173-1184, 2002.
35. A receptor blockade in patients with congestive heart failure. J Am Coll Cardiol 35: 1745-1752, 2000.
36. Steendijk P, Staal E, Jukema JW, and Baan J. Hypertonic saline method accurately determines parallel conductance for dual-field conductance catheter. Am J Physiol Heart Circ Physiol 281: H755-H763, 2001.
37. Steendijk P, Van der Velde ET, and Baan J. Left ventricular stroke volume by single and dual excitation of conductance catheter in dogs. Am J Physiol Heart Circ Physiol 264: H2198-H2207, 1993.
38. Suga H. Ventricular energetics. Physiol Rev 70: 247-277, 1990.
39. Sutsch G, Kiowski W, Yan XW, Hunziker P, Christen S, Strobel W, Kim JH, Rickenbacher P, and Bertel O. Short-term oral endothelin-receptor antagonist therapy in conventionally treated patients with symptomatic severe chronic heart failure. Circulation 98: 2262-2268, 1998.
40. Takeuchi Y, Kihara Y, Inagaki K, Yoneda T, and Sasayama S. Endothelin-1 has a unique oxygen-saving effect by increasing contractile efficiency in the isolated rat heart. Circulation 103: 1557-1563, 2001.
41. Teerlink JR, Breu V, Sprecher U, Clozel M, and Clozel JP. Potent vasoconstriction mediated by endothelin ETB receptors in canine coronary arteries. Circ Res 74: 105-114, 1994.
42. Thomas PB, Liu EC, Webb ML, Mukherjee R, Hebbar L, and Spinale FG. Exogenous effects and endogenous production of endothelin in cardiac myocytes: potential significance in heart failure. Am J Physiol Heart Circ Physiol 271: H2629-H2637, 1996.
43. Wagner OF, Christ G, Wojta J, Vierhapper H, Parzer S, Nowotny PJ, Schneider B, Waldhausl W, and Binder BR. Polar secretion of endothelin-1 by cultured endothelial cells. J Biol Chem 267: 16066-16068, 1992.
44. Wanecek M, Weitzberg E, Rudehill A, and Oldner A. The endothelin system in septic and endotoxin shock. Eur J Pharmacol 407: 1-15, 2000.
45. Warner TD, Allcock GH, Corder R, and Vane JR. Use of the endothelin antagonists BQ-123 and PD 142893 to reveal three endothelin receptors mediating smooth muscle contraction and the release of EDRF. Br J Pharmacol 110: 777-782, 1993.
46. Williams DL Jr, Jones KL, Pettibone DJ, Lis EV, and Clineschmidt BV. Sarafotoxin S6c: an agonist which distinguishes between endothelin receptor subtypes. Biochem Biophys Res Commun 175: 556-561, 1991.
47. 2+ signaling in guinea-pig ventricular myocytes: role of protein kinase C. J Mol Cell Cardiol 31: 631-643, 1999.
48. Yanagisawa M, Inoue A, Ishikawa T, Kasuya Y, Kimura S, Kumagaye S, Nakajima K, Watanabe TX, Sakakibara S, Goto K, and Masaki M. Primary structure, synthesis, and biological activity of rat endothelin, an endothelium-derived vasoconstrictor peptide. Proc Natl Acad Sci USA 85: 6964-6967, 1988.
49. 2+ transient and contractility in rabbit ventricular myocytes: pharmacological analysis with KB-R7943. Br J Pharmacol 126: 1785-1795, 1999.